Replies to post #17986 on Revive Therapeutics Ltd (RVVTF)

[Bbrasil]

Looks like trials have expanded into Canada, must be a good sign. The company wouldn't exhaust funds unless things were heading in the right direction.

[hotmeat]

Here are a few reasons why I believe Bucillamine will be approved and RVV is a safer investment..............

1) Bucillamine has been shown to be 16X more powerful, in terms of it's Covid combating action, than the already in use and effective NAC treatment.

Bucil vs NAC



2) The Covid Therapeutic breakthrough made recently by St Judes is virtually the same chemical action produced by Bucillamine, in addition to being the same class of drugs.

St Judes Covid therapy



3) Phase 3 Trials are well underway in multiple sites across the US (possibly +Canada?) with initial data expected in late December (210 patient milestone)

Clinical Trials



4) RVV is also well positioned to capitalize on the emerging Pychedelic market in the coming months/years. They are currently well into a sponsored research partnership with the Reed Research Group out of the University of Wisconsin-Madison. This only serves to secure RVV's position by being diversified rather than focused solely on Covid treatments.

Psilocybin Oral Strip